Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Journal of Biochemical Pharmaceutics ; (6): 81-82,85, 2015.
Artículo en Chino | WPRIM | ID: wpr-603217

RESUMEN

Objective To explore clinical effect of Cefdinir combined with Omidazole in treatment of pelvic inflammatory disease .Methods 60 cases of pelvic inflammatory disease from April 2014 to August 2015,were randomly divided into two groups and 30 cases in each group.Control group were given Ornidazole basic treatment, observation group were given Omidazole treatment given Cefdinir treatment on the basis of control group, after treated for 14d, patients were followed up and recorded C-reactive protein, blood rheology, compared clinical efficacy by statistical methods. Results After 2 weeks of treatment, observation group C-reactive protein value of (4.11 ±1.45)mg/L, lower than control group(7.63 ±1.57)mg/L (P<0.05).After 2 weeks of treatment, observation group plasma viscosity, hematocrit values were (1.12 ±0.26)mpass· s,(0.39 ±0.07)%, than control group (1.59 ±0.28)mpass· s,(0.48 ±0.09)% (P<0.05).After 2 weeks of treatment of patients in observation group total effective rate was 90.00%, significantly higher than 66.67%( P<0.05 ) .Conclusion It is good for Cefdinir combined with Omidazole in treatment of pelvic inflammatory disease better than Ornidazole medication use alone is worthy of further research and application .

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA